Scientists discover an essential mechanism in the immune response

July 5, 2017
Representative images lymph nodes in a control mouse (left) and a mouse lacking CTCF (right), showing germinal centers in the control mouse (red). Credit: CNIC

Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have discovered that the transcriptional regulator CTCF plays an essential role in antibody production. The study, led by Dr. Almudena Ramiro and published in Nature Communications, demonstrates that CTCF is essential for the ability of B lymphocytes to correctly protect the body against infection by pathogens. The research team shows that in the absence of CTCF, the immune system does not function correctly, a finding with implications for vaccine research.

B lymphocytes generate the that protect us against infection by pathogens. Explaining the background to the research, Dr. Ramiro describes how "an essential process in antibody generation takes place in structures called germinal centers, where antibody genes undergo small modifications that increase the efficiency and specificity of the immune response. The germinal reaction generates two types of cell: antibody-secreting plasma B , which combat infection, and memory B cells, which persist as a reservoir of cells that remember the first infection and permit a faster and more efficient immune activation in response to subsequent encounters with the same pathogen. The germinal centers are thus essential for the protective effect of vaccines."

The generation of the germinal centers requires B cells to undergo a complex transcriptional program to allow them to divide rapidly, modify their antibody genes, and pass through a selection procedure that induces either their survival or their death. In addition, adds Dr. Ramiro, "after completing this program, the B lymphocytes can differentiate into , which no longer proliferate but instead secrete large amounts of antibodies. These 2 transitions are coordinated by 2 transcriptional repressors: Bcl-6, the master regulator of the germinal center, and Blimp-1, which regulates the transcriptional program in plasma cells."

The study published today in Nature Communications analyzes the role played by CTCF in the germinal center differentiation program. For the study, the research team used mice engineered to lack CTCF specifically in germinal center B lymphocytes.

The team found that mice lacking CTCF were incapable of generating during the immune response. In vitro experiments and high-throughput RNA sequencing revealed that CTCF deletion profoundly altered the B lymphocyte transcriptional program, shifting cells from a gene expression profile typical of the germinal center to one more similar to that seen in plasma cells. Thus, in the absence of CTCF, Blimp-1 expression is activated prematurely, the cells do not proliferate normally, and they secrete antibodies precociously. "Together," explains Dr. Ramiro, "the results indicate that CTCF is important for maintaining the germinal center differentiation program and prevents premature differentiation towards plasma cells."

The scientists conclude that the study reveals an essential function for CTCF in the orchestration of transcriptional changes during the terminal differentiation of B lymphocytes and advances understanding of the mechanisms that regulate the .

Explore further: Genetic control of immune cell proliferation

More information: Arantxa Pérez-García et al, CTCF orchestrates the germinal centre transcriptional program and prevents premature plasma cell differentiation, Nature Communications (2017). DOI: 10.1038/NCOMMS16067

Related Stories

Genetic control of immune cell proliferation

April 19, 2017
Germinal centers are transient structures in the lymph nodes where antibody-producing B cells proliferate and differentiate at extraordinary rates. Germinal centers can be visually divided into a dark zone and light zone. ...

Efficient induction of immune cells that remember antigens

August 1, 2016
A group of researchers at Immunology Frontier Research Center (IFReC), Osaka University and RIKEN Center for Integrative Medical Sciences jointly clarified the mechanism for inducing germinal-center B cells' differentiation ...

Scientists publish new findings on differentiation and malignant transformation of B lymphocytes

November 30, 2015
B-cell lymphoma is one of the most common cancers derived from the lymphoid system. Lymphomagenesis is often linked to the so-called germinal center reaction. B lymphocytes represent a subgroup of the white blood cells, whose ...

New role discovered for a well-known gene in the survival of white blood cells

May 31, 2017
Researchers have clarified the role of a gene critical for the development of a type of white blood cells, known as B cells, which produce antibodies and serve as a "memory" for the immune system. This finding may open up ...

Research helps explain how B cell metabolism is controlled

January 23, 2017
B cells, the lymphocytes best known for making antibodies, live a complex life. They start developing in the bone marrow and then move through the spleen, lymph nodes and blood, taking on tasks that range from recognizing ...

Solving puzzle of B-cell lymphoma development

September 23, 2012
Germinal centers are sites in the organs of the lymphatic system, formed during the course of an immune response to infection, where B cells intensely proliferate and modify their DNA in order to produce antibodies specific ...

Recommended for you

The immune cells that help tumors instead of destroying them

December 12, 2017
Lung cancer is the leading cause of cancer-associated deaths. One of the most promising ways to treat it is by immunotherapy, a strategy that turns the patient's immune system against the tumor. In the past twenty years, ...

Cancer gene plays key role in cystic fibrosis lung infections

December 12, 2017
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But according to a new study from Columbia University Medical Center (CUMC), PTEN has a second, ...

Researchers bring new insight into Chediak-Higashi syndrome, a devastating genetic disease

December 12, 2017
A team of researchers from the National Institutes of Health and University of Manchester have uncovered new insights into a rare genetic disease, with less than 500 cases of the disease on record, which devastates the lives ...

Drug increases speed, safety of treatment for multiple food allergies

December 11, 2017
In a randomized, controlled phase-2 clinical trial, an asthma medication increased the speed and safety of a protocol used to treat children for several food allergies at once, according to a study by researchers at the Stanford ...

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease

December 9, 2017
Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening ...

Location, location, location: Immunization delivery site matters

December 1, 2017
In vaccination, a certain subpopulation of dendritic cells is vital to triggering the body's adaptive immune system, report researchers at The Jackson Laboratory (JAX), Yale University and Astra-Zeneca.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.